Test video microscopy to predict bleeding risk
Treatments studied
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study uses special video imaging to try to predict when bleeding may happen in certain inherited bleeding disorders. It may help doctors better anticipate bleeding and guide safer care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult
- You have one of these bleeding conditions: von Willebrand disease, Glanzmann thrombasthenia, moderate-to-severe hemophilia A, or you carry the hemophilia gene
- You must have health insurance coverage through the social insurance system
- You must agree to take part (consent required)
- You must not be pregnant
- You must not be under legal protection that limits study participation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1/2 study tests VGA039 in healthy adults and people with von Willebrand disease (VWD). The goal is to see if the drug is safe and how it affects bleeding-related factors, especially in people who have symptoms.
This study looks at genes and blood function in people with inherited (passed-down) problems with platelets, white blood cells, or blood clotting. It may help improve understanding of the cause of these conditions and how they work in the body.
This trial tests a new lab device that measures how well your body forms primary blood clots while blood is kept in flowing conditions. It may help doctors better assess bleeding or clotting tendencies and guide future care.
This study looks at cardiovascular problems and blood-clot events (like deep vein clots or pulmonary embolism) in adults with Von Willebrand disease in western France. It may help doctors better understand who is at risk and how to manage these complications.
This trial is testing a medication called eptacog beta (a clotting factor) to see if it helps control or prevent severe bleeding episodes in people with Glanzmann's thrombasthenia, a rare inherited bleeding disorder.
This study is for adults with Glanzmann thrombasthenia, a rare bleeding disorder. It aims to learn more about the condition and how to care for patients.
Hear when a new Glanzmann Thrombasthenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.